Changes in DPPX autoantibody levels in autoimmune encephalitis: a case report and brief review

Introduction: Dipeptidyl-peptidase-like protein-6 (DPPX) encephalitis is a recently recognized but rare cause of autoimmune encephalitis. Clinically, it presents with a subacute onset of seizures, cognitive decline, and tremors, often accompanied by gastrointestinal manifestations such as weight los...

Full description

Saved in:
Bibliographic Details
Main Authors: Abdalla Khabazeh, Volney Sheen
Format: Article
Language:English
Published: Elsevier 2025-06-01
Series:Brain Disorders
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666459325000459
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849435371483430912
author Abdalla Khabazeh
Volney Sheen
author_facet Abdalla Khabazeh
Volney Sheen
author_sort Abdalla Khabazeh
collection DOAJ
description Introduction: Dipeptidyl-peptidase-like protein-6 (DPPX) encephalitis is a recently recognized but rare cause of autoimmune encephalitis. Clinically, it presents with a subacute onset of seizures, cognitive decline, and tremors, often accompanied by gastrointestinal manifestations such as weight loss and vomiting. Temporal fluctuations in DPPX antibody levels have not been previously reported and diagnosing this subtype remains challenging due to its gradual onset, diverse clinical presentation, and possible fluctuations in antibody levels throughout the disease course. Its pathophysiology is incompletely understood, likely involving genetic, environmental, and immune factors. Case report: We describe a 22-year-old male presenting with a clinical syndrome consistent with DPPX encephalitis, including seizures, cognitive impairment, and systemic manifestations. Serum testing revealed antibodies to DPPX and voltage-gated potassium channels (VGKC), confirmed by a cell-based assay. The assay was repeated at the initial presentation and was again positive. However, repeat testing several months later, prior to treatment, showed negative cerebrospinal fluid (CSF) and serum DPPX antibodies. Repeat testing on a third occasion also returned negative results. The patient improved significantly after immunotherapy, consistent with an autoimmune encephalitis diagnosis. Conclusion: This case highlights the diagnostic challenges of DPPX encephalitis, emphasizing the importance of interpreting encephalopathy panel results within the clinical context. The observed fluctuations in DPPX antibody levels suggest that repeat serum testing may be of utility to reassess diagnosis and guide treatment in clinical cases where there is concern for autoimmune encephalitis.
format Article
id doaj-art-08fbdf149cb14fbd9f85acb5080aa0ed
institution Kabale University
issn 2666-4593
language English
publishDate 2025-06-01
publisher Elsevier
record_format Article
series Brain Disorders
spelling doaj-art-08fbdf149cb14fbd9f85acb5080aa0ed2025-08-20T03:26:20ZengElsevierBrain Disorders2666-45932025-06-011810022510.1016/j.dscb.2025.100225Changes in DPPX autoantibody levels in autoimmune encephalitis: a case report and brief reviewAbdalla Khabazeh0Volney Sheen1Department of Neurology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02115, USACorresponding author.; Department of Neurology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02115, USAIntroduction: Dipeptidyl-peptidase-like protein-6 (DPPX) encephalitis is a recently recognized but rare cause of autoimmune encephalitis. Clinically, it presents with a subacute onset of seizures, cognitive decline, and tremors, often accompanied by gastrointestinal manifestations such as weight loss and vomiting. Temporal fluctuations in DPPX antibody levels have not been previously reported and diagnosing this subtype remains challenging due to its gradual onset, diverse clinical presentation, and possible fluctuations in antibody levels throughout the disease course. Its pathophysiology is incompletely understood, likely involving genetic, environmental, and immune factors. Case report: We describe a 22-year-old male presenting with a clinical syndrome consistent with DPPX encephalitis, including seizures, cognitive impairment, and systemic manifestations. Serum testing revealed antibodies to DPPX and voltage-gated potassium channels (VGKC), confirmed by a cell-based assay. The assay was repeated at the initial presentation and was again positive. However, repeat testing several months later, prior to treatment, showed negative cerebrospinal fluid (CSF) and serum DPPX antibodies. Repeat testing on a third occasion also returned negative results. The patient improved significantly after immunotherapy, consistent with an autoimmune encephalitis diagnosis. Conclusion: This case highlights the diagnostic challenges of DPPX encephalitis, emphasizing the importance of interpreting encephalopathy panel results within the clinical context. The observed fluctuations in DPPX antibody levels suggest that repeat serum testing may be of utility to reassess diagnosis and guide treatment in clinical cases where there is concern for autoimmune encephalitis.http://www.sciencedirect.com/science/article/pii/S2666459325000459EncephalitisAutoimmuneSeizuresTremorsImmunotherapyCase report
spellingShingle Abdalla Khabazeh
Volney Sheen
Changes in DPPX autoantibody levels in autoimmune encephalitis: a case report and brief review
Brain Disorders
Encephalitis
Autoimmune
Seizures
Tremors
Immunotherapy
Case report
title Changes in DPPX autoantibody levels in autoimmune encephalitis: a case report and brief review
title_full Changes in DPPX autoantibody levels in autoimmune encephalitis: a case report and brief review
title_fullStr Changes in DPPX autoantibody levels in autoimmune encephalitis: a case report and brief review
title_full_unstemmed Changes in DPPX autoantibody levels in autoimmune encephalitis: a case report and brief review
title_short Changes in DPPX autoantibody levels in autoimmune encephalitis: a case report and brief review
title_sort changes in dppx autoantibody levels in autoimmune encephalitis a case report and brief review
topic Encephalitis
Autoimmune
Seizures
Tremors
Immunotherapy
Case report
url http://www.sciencedirect.com/science/article/pii/S2666459325000459
work_keys_str_mv AT abdallakhabazeh changesindppxautoantibodylevelsinautoimmuneencephalitisacasereportandbriefreview
AT volneysheen changesindppxautoantibodylevelsinautoimmuneencephalitisacasereportandbriefreview